Clinical trials
Active, not recruiting Phase 1/2 Small Cell Lung Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 23andMe, Inc. | 1 |
| AstraZeneca | 1 |
| Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Klus Pharma Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Monte Rosa Therapeutics, Inc | 1 |
| National Cancer Institute (NCI) | 1 |
| OncoC4, Inc. | 1 |
| Salubris Biotherapeutics Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 11 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Breast Neoplasms | 4 |
| Carcinoma, Ovarian Epithelial | 3 |
| Carcinoma, Renal Cell | 3 |
| Carcinoma, Transitional Cell | 3 |
| Prostatic Neoplasms | 3 |
| Colorectal Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Melanoma | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.